← Eichor
Condition: Secondary Hyperparathyroidism Shpt Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Secondary Hyperparathyroidism Shpt

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemo
Phase 3 · 43 location(s) · Amgen · NCT03633708Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease
Phase 2 · 1 location(s) · Shaanxi Micot Pharmaceutical Technology Co., Ltd. · NCT06976177A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Phase 3 · 23 location(s) · Amgen · NCT03969329Parathyroid Tumor Clonal Status
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT05997810
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.